NCT04500587 2024-09-19Phase 1 First in Human Study of ZN-d5 as a Single AgentK-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.Phase 1 Completed39 enrolled